How effective is dupilumab treatment for prurigo nodularis?

Prurigo nodularis causes intensely itchy, firm bumps that can persist when scratching keeps the itch–scratch cycle active. Dupilumab targets immune pathways linked with this inflammation. A useful response may include less urge to scratch, fewer new nodules, softer or flatter existing lesions, and improved sleep. Established bumps may take longer to settle than the itch. The medicine is part of a broader plan and does not replace skin protection or treatment of an identified trigger.

Follow the injection plan and use the skin care measures your clinician recommends. Keep nails short, cover areas you scratch during sleep if advised, and note itch intensity, new nodules, sleep disruption, and injection dates. Report persistent or worsening symptoms rather than adding over-the-counter medicines on your own. Your dermatologist may adjust accompanying treatment after examining the nodules and checking for infection or another diagnosis.

Arrange prompt review for painful, hot, draining, or rapidly enlarging nodules, fever, or redness spreading beyond scratched skin. Seek urgent help for breathing trouble, swelling of the lips or throat, faintness, or a severe blistering reaction after an injection. New widespread symptoms should not be assumed to be ordinary prurigo nodularis or a temporary treatment adjustment.

Ask what improvement to look for first, how long to continue before reviewing the plan, which anti-itch measures are compatible with dupilumab, and how to respond to an injection reaction or missed dose.